In the present study, we aimed to characterize IDH1 and IDH2 mutations in newly diagnosed AML patients and investigate their correlations to other parameters such as clinical and hematologic characteristics, cytogenetics and additional genetic mutations. Here, IDH2 is linked to acute myeloid leukemia.